News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,811 Results
Type
Article (48490)
Company Profile (347)
Press Release (676974)
Section
Business (211224)
Career Advice (2099)
Deals (36395)
Drug Delivery (107)
Drug Development (82869)
Employer Resources (171)
FDA (16762)
Job Trends (15619)
News (357193)
Policy (34852)
Tag
Academia (2805)
Alliances (51343)
Alzheimer's disease (1310)
Approvals (16719)
Artificial intelligence (161)
Bankruptcy (360)
Best Places to Work (12202)
Biotechnology (231)
Breast cancer (194)
Cancer (1403)
Cardiovascular disease (116)
Career advice (1759)
Cell therapy (289)
Clinical research (66137)
Collaboration (505)
Compensation (263)
COVID-19 (2723)
C-suite (115)
Data (1407)
Diabetes (185)
Diagnostics (6509)
Drug pricing (101)
Earnings (86485)
Employer resources (149)
Events (118275)
Executive appointments (408)
FDA (17470)
Funding (451)
Gene therapy (206)
GLP-1 (640)
Government (4862)
Healthcare (20167)
Infectious disease (2821)
Inflammatory bowel disease (114)
Interviews (329)
IPO (16674)
Job creations (3846)
Job search strategy (1500)
Layoffs (436)
Legal (8414)
Lung cancer (201)
Manufacturing (217)
Medical device (13860)
Medtech (13865)
Mergers & acquisitions (19885)
Metabolic disorders (488)
Neuroscience (1645)
NextGen Class of 2024 (7098)
Non-profit (4900)
Northern California (1719)
Obesity (280)
Opinion (208)
Patents (122)
People (58969)
Phase I (20644)
Phase II (28994)
Phase III (21638)
Pipeline (517)
Postmarket research (2757)
Preclinical (8766)
Radiopharmaceuticals (248)
Rare diseases (280)
Real estate (6176)
Regulatory (23065)
Research institute (2519)
Resumes & cover letters (361)
Southern California (1499)
Startups (3786)
United States (15762)
Vaccines (625)
Weight loss (202)
Date
Today (126)
Last 7 days (599)
Last 30 days (2457)
Last 365 days (36485)
2024 (36322)
2023 (41347)
2022 (52602)
2021 (57322)
2020 (56301)
2019 (49440)
2018 (37432)
2017 (33561)
2016 (33633)
2015 (39690)
2014 (33357)
2013 (28362)
2012 (30555)
2011 (31217)
2010 (29446)
Location
Africa (834)
Arizona (213)
Asia (39960)
Australia (6645)
California (3910)
Canada (1466)
China (313)
Colorado (177)
Connecticut (193)
Europe (86907)
Florida (544)
Georgia (146)
Illinois (415)
Indiana (233)
Maryland (665)
Massachusetts (3076)
Michigan (193)
Minnesota (308)
New Jersey (1144)
New York (1113)
North Carolina (806)
Northern California (1719)
Ohio (150)
Pennsylvania (939)
South America (1209)
Southern California (1499)
Texas (568)
Utah (113)
Washington State (414)
725,811 Results for "accredo health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Delivery
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
Starting in June 2024, Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty pharmacy.
April 26, 2024
·
2 min read
·
Tristan Manalac
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Bio NC
SNP Therapeutics Inc and Fullscript announce Genate test integration to support health professional precision nutrition recommendations in reproductive health
SNP Therapeutics Inc announced today that its Genate Prenatal Nutrition Test can now support healthcare professionals utilizing the Fullscript platform.
June 26, 2024
·
3 min read
Biotech Bay
Jaguar Health, Inc. Announces Reverse Stock Split - May 17, 2024
Jaguar Health, Inc. announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock, at an exchange ratio of 1-for-60, on Thursday, May 23, 2024 in order to support the Company’s compliance with Nasdaq’s listing standards.
May 17, 2024
·
5 min read
BioCapital
Empowering Change: AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship
Intern alumni from Moda Health and Novo Nordisk Inc. join forces with the AMCP Foundation for a groundbreaking Health Disparities research internship, appointing Daria Sinclair, a PharmD Candidate at Howard University, College of Pharmacy, as the inaugural intern.
April 3, 2024
·
4 min read
BioMidwest
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
Inspire Medical Systems, Inc. announced that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.
April 30, 2024
·
1 min read
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time.
May 9, 2024
·
1 min read
Press Releases
Revival Health Inc. Partners With BSS Health to Bring Affordable GLP-1 Obesity Medication to Mississippians Following Policy Change at Mississippi Board of Medical Licensure
October 16, 2024
·
5 min read
Business
Oscar Health, Inc. 2024 First Quarter Conference Call
Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
April 2, 2024
·
1 min read
BioMidwest
Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight® Mental Health Monitor: Special Election Series, a nationwide survey from Myriad Genetics, Inc., a leader in genetic testing and precision medicine.
June 24, 2024
·
5 min read
1 of 72,582
Next
